Summit Therapeutics
SMMT
#1896
Rank
A$15.47 B
Marketcap
A$20.78
Share price
3.77%
Change (1 day)
-35.33%
Change (1 year)

Summit Therapeutics (SMMT) - Net assets

Net assets on the balance sheet as of September 2025 : A$0.27 Billion

According to Summit Therapeutics 's latest financial reports the company has A$0.27 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Summit Therapeutics - Net assets on balance sheet (from 2014 to 2020)

Net assets by year

Year Net assets Change
2024-12-31$A$0.62 B448.07%
2023-12-31$A$0.11 B-38.73%
2022-12-31$A$0.18 B62.01%
2021-12-31$A$0.11 B11.18%
2020-12-31$A$0.10 B
2019-01-31$A$76.9 M-1496.35%
2018-01-31$-A$5.51 Million-23.66%
2017-01-31$-A$7.22 Million-122.32%
2016-01-31$A$32.32 M-26.67%
2015-01-31$A$44.08 M393.65%
2014-01-31$A$8.93 M30.79%
2013-01-31$A$6.82 M21.79%
2012-01-31$A$5.6 M-39.92%
2011-01-31$A$9.33 M-61.05%
2010-01-31$A$23.95 M-11.08%
2009-01-31$A$26.93 M-77.59%
2008-01-31$A$0.12 B18.41%
2007-01-31$A$0.10 B82.94%
2006-01-31$A$55.5 M-13.96%
2005-01-31$A$64.51 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sarepta Therapeutics
SRPT
A$1.88 B 586.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
A$0.31 B 15.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
A$0.12 B-54.35%๐Ÿ‡บ๐Ÿ‡ธ USA